1. Department of Genetics and Molecular Pathology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia;
2. School of Pharmacy and Medical Science, Division of Health Sciences, University of South Australia, Adelaide, Australia;
3. School of Medicine, Faculty of Health and Medical Sciences, and
4. School of Biological Sciences, Faculty of Sciences, University of Adelaide, Adelaide, Australia;
5. Australian Cancer Research Foundation Genomics Facility and
6. Department of Haematology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia;
7. South Australian Health and Medical Research Institute, Adelaide, Australia;
8. Australasian Leukaemia and Lymphoma Group, Melbourne, Australia;
9. Institute for Hematology and Oncology, Mannheim, Germany;
10. Department of Haematological Medicine, King’s College London, London, United Kingdom;
11. Korea Leukemia Bank,
12. Catholic Leukemia Research Institute, and
13. Department of Hematology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea;
14. Division of Health Sciences, University of South Australia, Adelaide, Australia; and
15. Department of Haematology, Flinders University and Medical Centre, Bedford Park, Australia